AIM
TEAR

Acrospire Investment Management’s TearLab Corporation TEAR Stock Holding History

Acrospire Investment Management’s Portfolio TEAR Stock Details TEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,200
Closed -$7K – 2055
2017
Q2 		$7K Buy
+4,200
New +$8.54K 0.01% 1910

Other funds holding TEAR

AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JPMIA
J.P. Marvel Investment Advisors Boston, Massachusetts $871M AUM 64.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Acrospire Investment Management's TEAR Position: Q3 2017 in Review

Acrospire Investment Management sold out of TearLab Corporation (TEAR) in Q3 2017, closing a stake of 4,200 shares — an estimated $7K sold.

Acrospire Investment Management first reported a position in TEAR in Q2 2017 and held it in 1 quarter. The position peaked at $7K in Q2 2017. 19 funds tracked by Wall St. Rank hold TEAR as of Q3 2017.

  • Acrospire Investment Management reported no remaining TearLab Corporation position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 4,200 TearLab Corporation shares in Q3 2017, an estimated $7K.
  • Acrospire Investment Management first reported a position in TearLab Corporation in Q2 2017 and held it in 1 quarter.
  • Acrospire Investment Management's TearLab Corporation position peaked at $7K in Q2 2017.
  • 19 funds tracked by Wall St. Rank held TearLab Corporation as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.